CLEC5A Antibody from CREATIVE BIOLABS, INC.
Search, find, compare suppliers for anti-CLEC5A antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CLEC5A |
| Clone | monoclonal |
| Host Species | Recombinant Mouse |
| Reactive Species | n/a |
| Isotype | n/a |
| Format | unconjugated |
| Size | n/a |
| Concentration | n/a |
| Applications | ELISA; |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Recombinant Anti-CLEC5A (ECD domain) Antibody (V3S-0622-YC1417). This product is a monoclonal antibody derived from mouse, which can specifically recognize CLEC5A. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation. Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free. |
| Immunogen | Extracellular domain of human MDL-1 |
| Other Names | CLEC5A; C-type lectin domain family 5, member A; MDL1; MDL-1; CLECSF5; C-type lectin domain family 5 member A; C-type lectin superfamily member 5; myeloid DAP12-associating lectin 1; myeloid DAP12-associating lectin-1; C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamily member 5 |
| Gene, Accession # | UniProt: Q14DL9 |
| Catalog # | V3S-0622-YC1417 |
| Price | please inquire |
| Order / More Info | CLEC5A Antibody from CREATIVE BIOLABS, INC. |
| Product Specific References | n/a |
CREATIVE BIOLABS, INC.
CREATIVE BIOLABS, INC.
Suite 203
17 Ramsey Road
Shirley NY 11967
P: 1-631-416-1478
F: 1-631-207-8356
info@creative-biolabs.com
http://www.creative-biolabs.com
Profile of CREATIVE BIOLABS, INC.
Return to Antibodies